Become A Featured Company

BlissCo Cannabis Corp Announces License Amendment Application to Produce Cannabis Oil

Ryan Allway

June 13th, 2018

News, Top News

  • BlissCo applies for ACMPR cannabis oil license amendment
  • BlissCo to produce 420 kilos of cannabis oil in phase one
  • BlissCo brings the first Midas XII Co2 extractor to Canada

VANCOUVER, June 13, 2018 /CNW/ – BlissCo Cannabis Corp. (CSE: BLIS) (FRA: GQ4B), (“BlissCo”) submitted a license amendment application to Health Canada to produce cannabis oil on June 6, 2018.

Vanguard Scientific Systems, MIDAS XII Co2 Extraction System (CNW Group/BlissCo Cannabis Corp.)

“The BlissCo team with the support of two international partners has designed a state of the art cannabis oil extraction lab, that in phase one will be able to produce 420 kilograms of cannabis oil annually. These 420 kilograms of cannabis oil will be used to create cannabis oil tinctures and capsules to service Canadian medical patients and international distribution partners,” said BlissCo CEO Damian Kettlewell.

The most recent sales data from Health Canada shows that cannabis oil sales overtook dried cannabis sales in May 2017 and as of December 2017 cannabis oil sales are 50% higher than dried cannabis sales.

“BlissCo is focused on creating value added, high margin cannabis products for the medical market and the recreational market in Canada when it is legal. Our international supply chain partnerships will ensure that BlissCo has access to rapidly evolving cannabis consumer and product data,” said Kettlewell.

One such partnership gives BlissCo access to medical-grade cannabis oil through the MIDAS XII Co2 extraction system created by Oregon-based, Vanguard Scientific Systems. Created with the user and final patient in mind, a proprietary two-column design makes the MIDAS one of the only systems in the world with the ability to safely extract therapeutic cannabis terpenes along with the healing whole plant oils, offering a full spectrum of benefits to users.

“BlissCo is excited to bring the first Midas Co2 extractor to Canada and introduce innovative and compliant cannabis oil products to our medical patients and adult users when legal,” said Kettlewell.

The MIDAS represents a significant investment in the BlissCo extraction lab, allowing the company to utilize dozens of cannabis components that were previously inaccessible. As a result, the 420 kilograms of cannabis oil have the potential to generate tens of millions in sales annually for BlissCo depending on the final products that are created and on the evolution of the cannabis extract market.

“The MIDAS Co2 extractor is the culmination of six years of research by scientists and technology pioneers from around the world,” says Vanguard CEO, Matthew Anderson. “We are excited to help bring a new level of plant-based therapeutics to Canadians across the country with the partnership of BlissCo and the forward-thinking support of the Canadian federal government. Extracting cannabis oil can be extremely complex, but with the patented design of the MIDAS, Canadians will soon have access to the world’s purest cannabis oil.”

Stock Option Grant

The Company announces that it has granted 450,000 stock options (the “Options”) to employees and Consultants, at an exercise price of $0.33per Option. Each Option will have an exercise term of up to three (3) years and vesting will be determined by management.

About BlissCo Cannabis Corp

BlissCo (CSE: BLIS) (FRA: GQ4B) owns through its wholly-owned subsidiary BlissCo Holdings Ltd., a license to produce marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR) which was originally granted on March 29, 2018.

BlissCo began growing medical cannabis in early May 2018 and applied to Health Canada to amend its ACMPR license to include cannabis oil production in early June 2018.

BlissCo is projected to have a sales license inspection from Health Canada in August 2018 and earn a sales license in September 2018 to sell dried cannabis.

BlissCo’s value proposition is to be a brand focused high-volume distributor, processor and packager of medical cannabis and adult use cannabis when it is legal in Canada.

BlissCo will be processing and distributing cannabis purchased from multiple supply agreements and from cannabis grown at its own start of the art facility in Metro Vancouver, B.C. Currently, BlissCo has a two-year supply agreement with The Supreme Cannabis Company Inc (TSX.V: FIRE) to purchase 3,000 kilograms of premium whole dried cannabis flower.

BlissCo is currently exploring brand expansion opportunities in multiple international markets where medical cannabis is federally legal.

Management is focused on establishing BlissCo as an iconic Canadian cannabis brand.

On Behalf of the Board of Directors

BLISSCO CANNABIS CORP.

Damian Kettlewell, CEO, Founder & Chair

Cautionary Statement

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the ability to execute on our strategic plans and the impact on our future operations, capital expenditures, receipt of a cannabis oil license and a license to sell dried cannabis and other objectives, the production capacity of our cannabis oil extraction lab, our access to consumer and market data, and our ability to generate sales from cannabis oil.  Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.

SOURCE BlissCo Cannabis Corp.

View original content with multimedia: http://www.newswire.ca/en/releases/archive/June2018/13/c8019.html

Damian Kettlewell, CEO, (604) 484 9119, ext. 3, damian.kettlewell@blissco.comCopyright CNW Group 2018

 

Source: Canada Newswire (June 13, 2018 – 5:00 AM EDT)

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading